Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Pramodini Medicare IPO
Price Band
₹110.0–118.0
Issue Size
₹69.04 Cr
Lot Size
1,200 shares
Min Investment
₹283,200
2 LOTS MIN
GMP
—
Issue Price
₹118.0
Pramodini Medicare IPO AI Summary
- Pramodini Medicare IPO is listed on NSE SME in the Healthcare Service Provider sector.
- Price band: ₹110.0–₹118.0 per share, lot size 1,200 shares (min. investment ₹283,200, 2 lots minimum).
- Subscription window: 12 Aug–14 Aug 2026, listing on 19 Aug 2026.
Pramodini Medicare Limited is a healthcare service provider focusing on diagnostic services across India. With a strong growth trajectory in revenue and profit, the company aims to utilize the IPO proceeds for expanding its operations and enhancing its service offerings.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Important Dates
Subscription Status
Overall Subscription
3.87x
| Category | Subscription | Status |
|---|---|---|
| QIB (Institutional) |
3.66x
|
3.66x |
| NII (HNI) |
4.96x
|
4.96x |
| ↳ bNII (>₹10L) |
5.03x
|
5.03x |
| ↳ sNII (<₹10L) |
4.82x
|
4.82x |
| Retail (RII) |
3.49x
|
3.49x |
| Total | 3.87x | 3.87x |
Auto-updated every 5 min · As of 14th Aug 2026 18:56
Pramodini Medicare IPO Grey Market Premium (GMP) Today
GMP not available yet
Grey Market Premium is updated daily. Check back closer to the listing date.
About the Company
Incorporated in 2000, Pramodini Medicare Limited is a diagnostic service provider in India offering technology-enabled diagnostic services across radiology, clinical laboratory, and nuclear medicine segments. The company provides services to public hospitals, private hospitals, public sector undertakings (PSUs), medical colleges, and private diagnostic centres across tier I, II, and III cities. Its service portfolio includes radiology services such as MRI, CT scans, X-ray, ultrasound with colour doppler, mammography, Dexa scan, and interventional radiology; clinical laboratory services including haematology, microbiology, immunology, pathology, and biochemistry; and nuclear medicine services such as PET-CT, SPECT, and nuclear therapy. The company also operates a 24×7 teleradiology unit from Vijayawada and a processing laboratory at the same location. Service Model Public-Private Partnership (PPP): Operates diagnostic centres within government hospitals and medical colleges through long-term MOUs. Private-Private Partnership (Pvt-Pvt): Establishes and manages diagnostic centres inside private hospitals under partnership agreements. Strategic Partnerships with PSUs: Collaborates with Government of India PSUs to operate diagnostic and imaging centres across multiple states. Standalone Diagnostic Centres: Operates its own diagnostic centres and laboratories, serving both individual patients and hospitals. Location-Specific Agreements: Each diagnostic centre operates under separate MOUs or contracts with terms customized for the respective location. The business operates through four models: public-private partnership (PPP) with government hospitals and teaching institutions, private-private partnerships with hospitals, strategic partnerships with PSUs, and standalone private diagnostic centres. As of August 04, 2026, the company operated 16 diagnostic centres across seven states. As of March 31, 2026, the company had 161permanent employees. Competitive Strengths: Establishing a strategic presence across various states of India. Strengthening its network through diversified business models. Strong technical capabilities supported by robust IT infrastructure. Experienced management team with significant industry expertise. Consistent track record of revenue growth and financial performance. Diverse customer base, including hospitals, institutions, and individual patients.
Company Financials (₹ Cr)
As of 2026-03-31
| Period Ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 93.62 | 56.45 | 48.78 |
| Total Income | 63.38 | 38.55 | 35.79 |
| Profit After Tax | 17.38 | 11.14 | 7.14 |
| EBITDA | 30.90 | 20.97 | 15.53 |
| NET Worth | 53.15 | 35.77 | 24.75 |
| Reserves and Surplus | 36.46 | 34.49 | 23.46 |
| Total Borrowing | 17.85 | 10.81 | 11.96 |
Key Ratios
EPS
₹10.41
NAV
₹31.84
ROE
39.08%
ROCE
34.66%
RoNW
32.69%
P/B Value
3.71
P/E Ratio
11.34
Market Cap
₹260.14 Cr
PAT Margin
27.90%
Debt/Equity
0.34
Peer Comparison
| Company | NAV | RoNW | P/E (x) | EPS Basic | EPS Diluted |
|---|---|---|---|---|---|
| Star Imaging & Path Labs Ltd. | 66.65 | 16.58% | 7.87 | 11.05 | 11.05 |
| Krsnaa Diagnostics Ltd. | 302.23 | 10.35% | 16.74 | 31.3 | 31.3 |
| Invicta Diagnostic Ltd. | 39.71 | 9.76% | 13.62 | 4.9 | 4.9 |
| Pramodini Medicare Ltd. This IPO | 31.84 | 32.69% | — | 10.41 | 10.41 |
Promoters
Chalasani Kuldeep Kumar, Chalasani Kavitha, Chalasani Durga Aashritha, Chalasani Lalithakumar, Sri Ram Medicare Pvt.Ltd.
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Funding of capital expenditure for purchase of Medical Equipments towards Existing and Proposed Diagnostic Centres 45.15 2 General corporate purposes and unidentified inorganic acquisition Total 45.15
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total income was ₹35.79 Cr in the year ending 31 Mar 2024, rising to ₹38.55 Cr by 31 Mar 2025, and further increasing to ₹63.38 Cr by 31 Mar 2026. This demonstrates a consistent upward trend in revenue over the three periods.
Profit Trend
Profit After Tax was ₹7.14 Cr for the year ending 31 Mar 2024, increasing to ₹11.14 Cr by 31 Mar 2025, and reaching ₹17.38 Cr by 31 Mar 2026. This indicates a strong growth in profitability over the observed periods.
Valuation
Priced at a P/E ratio of 11.34 based on an EPS of ₹10.41, this IPO is positioned against peers with P/E ratios ranging from 7.87 to 16.74.
Grey Market Premium, Explained
The grey market refers to the unofficial trading of shares before they are listed on the stock exchange. The Grey Market Premium (GMP) indicates the expected listing price of an IPO based on these trades. A higher GMP suggests strong demand, while a lower or negative GMP can indicate weaker interest.
Subscription Demand
As of 14th Aug 2026, the overall subscription was 3.87 times, with significant interest from different categories: QIBs subscribed 3.66 times, NIIs 4.96 times, and Retail investors 3.49 times.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their risk tolerance, investment goals, and market conditions.
Who May Want to Wait
Investors who prefer stable returns and lower risk profiles might consider avoiding IPOs, as they can be subject to market fluctuations and uncertainties.
IPO Timeline, Explained
The IPO opens for subscription from 12th August 2026 to 14th August 2026, with allotment scheduled for 17th August 2026 and listing on 19th August 2026.
Listing Gains — The Risk
Listing-day gains can be unpredictable and depend on market conditions, investor sentiment, and demand for the shares. Investors should be aware that while some IPOs may see immediate gains, others may not perform as expected.
This evaluation is generated from Pramodini Medicare's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is the price band of Pramodini Medicare IPO?
The price band of Pramodini Medicare IPO is ₹110.0–₹118.0 per share.
When does Pramodini Medicare IPO open and close?
Pramodini Medicare IPO opens on 12 August 2026 and closes on 14 August 2026.
When does Pramodini Medicare IPO list on the stock exchange?
Pramodini Medicare IPO listed on 19 August 2026 at ₹118.0.
What is the lot size for Pramodini Medicare IPO?
The lot size for Pramodini Medicare IPO is 1200 shares, requiring a minimum investment of ₹283,200 (2 lots).
What is the price band for the IPO?
The price band for the IPO is ₹110.0 to ₹118.0.
What is the minimum investment required?
The minimum investment required is ₹283,200, which corresponds to a lot size of 1200 shares.
When does the IPO open and close?
The IPO opens on 12th August 2026 and closes on 14th August 2026.
What is the allotment date for the shares?
The allotment date for the shares is 17th August 2026.
When will the shares be listed?
The shares will be listed on 19th August 2026.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
12 Aug 2026
Close
14 Aug 2026
Allotment
17 Aug 2026
Listing
19 Aug 2026
Similar IPOs in Healthcare Service Provider
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Pramodini Medicare?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.